PET used in study of pancreatic cancer treatment

06/26/2008 |

PET imaging was used in a study of chemotherapy plus radiotherapy, combined with nelfinavir, a protease inhibitor, in locally advanced pancreatic cancer patients. Of the nine study participants who had PET scans, two showed no response to the therapy and the rest showed partial or complete response.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL